More Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025
1.5.2025 08:00:00 CEST | Business Wire | Press Release
Varian, a Siemens Healthineers company, will showcase an integrated portfolio designed to streamline workflows, and aiming to enhance patient experience and improve patient outcomes from screening to survivorship at the 2025 European Society for Radiotherapy and Oncology (ESTRO) annual meeting, May 2-6, in Vienna, Austria.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430039992/en/
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight.
“As part of Siemens Healthineers, we are uniquely positioned to transform cancer and beyond, and we are supercharging our commitment to patient-centricity with greater scale and impact,” said Arthur Kaindl, Head of Varian. “Our accelerated pace of innovation demonstrates that we offer more impact, together, in our mission toward a world without fear of cancer.”
Varian and Siemens Healthineers will announce ground-breaking technologies empowering access to MRI for radiotherapy practices with the goal of establishing MRI in daily clinical routine, as well as showcase how its RapidArc Dynamic solution enables greater efficiency, precision, and flexibility in treatment planning and delivery at its booth (ESTRO #250), Friday, May 2, at 19:04 CEST.
Varian’s RapidArc Dynamic solution, available as an optional feature for the latest versions of Eclipse treatment planning software and the TrueBeam radiotherapy delivery platform, is powered by next-generation algorithms, combining a dynamic collimator and modulated ports working seamlessly in a single arc treatment field to provide clinicians with supreme control for optimal dose delivery.
More innovations, together
With the latest version of the ARIA CORE oncology management solution, Varian has strengthened integration with its software solutions, Noona and ARIA CORE Insights, to provide a seamless user experience and help streamline clinical workflows. Varian will also introduce ARIA CORE Automations, enabling users to automate workflows within ARIA CORE to drive efficiency and establish standardization.
As an example of Varian and Siemens Healthineers’ expanded strength as one team, Siemens Healthineers will be introducing Oncology Exchange, which improves integration by automatically transferring ARIA CORE prescription information to setup and configure the CT simulator.
Reflecting the growing use of MRI in radiation therapy, Siemens Healthineers will present dedicated deep-learning algorithms for MRI autocontouring of brain metastases, and autocontouring of brain organs at risk – optimized for use with HyperArchigh-definition radiotherapy.
More breakthroughs, together
With almost 40 Varian-supported abstracts accepted as part of ESTRO 2025, Varian is proud to collaborate with research leaders in the field.
Included in this year's ESTRO program is evidence generated by Varian-sponsored clinical trials and consortium members underscoring the value of Varian’s HyperSight imaging, an optional feature for selected Varian linacs, and Varian’s Ethos adaptive radiotherapy system.
“We recognize that every step of the cancer care journey needs to be effective and efficient, and delivered at the highest possible levels of clinical confidence and patient experience,” Kaindl said. “We are committed to driving sustainable innovations that introduce new and enhanced tools in the fight against cancer.”
© 2025 VARIAN MEDICAL SYSTEMS, INC. All trademarks are the property of their respective owners.
QR700022422
About Varian
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250430039992/en/
Contacts
Varian Press Contact
Kristin Corey
Varian Corporate Communications
Kristin.Corey@varian.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortune Media and Great Place To Work Name Experian As One Of The ‘100 Best Companies to Work For Europe’ in 2026 for Second Year8.10.2026 09:00:00 CEST | Press Release
Great Place To Work® and Fortune Europe have recognised Experian as one of the Fortune 100 Best Companies to Work For™ Europe for the second-year running. The 100 Best Companies to Work For Europe list is a comprehensive recognition for business excellence and employee experience, based on Great Place To Work’s proprietary Trust Index™ Survey. Great Place To Work evaluates confidential feedback from employees, validating against HR data from participating companies. Only companies with consistently high survey responses from employees — regardless of their role, department, or status in the company — are honored with placement on the list. Eligible companies have 500 or more employees and were represented on at least one national Best Workplaces™ List in Europe. Jacky Simmonds, Chief People Officer, Experian, said: “We are thrilled to being named one of the Fortune 100 Best Companies to Work For™ in Europe for the second year in a row. It’s an incredibly proud moment for us at Experian
Value Group Brings Its Integrated Global IROPS Management Model to the World Aviation Festival8.10.2026 08:32:00 CEST | Press Release
Value Group, a leading provider of integrated aviation disruption management solutions, returns to the World Aviation Festival as a Gold Sponsor, reinforcing its role in the evolution of airline disruption management. From 13 to 15 October at FIL in Lisbon, the event is one of the aviation industry’s leading international technology conferences and exhibitions, bringing together airlines, airports and travel technology companies worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007885823/en/ Thomas Sergnese, Co-CEO & Chief Commercial Officer and Daniele Bocchieri, Co-CEO & Chief Operating Officer At stand 1-180, Value Group will showcase the evolution of its integrated disruption management model and the RUBIK digital ecosystem, demonstrating how technology, operations and governance can work together as one connected system to manage irregular operations more effectively at both global and local level. Over the p
Colruyt Group Crosses the 150 Store Milestone With Rollout of Toshiba ELERA® Self Service Store Deployments8.10.2026 07:30:00 CEST | Press Release
Toshiba Global Commerce Solutions today announced the successful deployment of its ELERA® Self Service solution across 144 Colruyt Group stores: Okay, Okay City, Spar Colruyt Group and Bio-Planet. Today, 454 self-checkout systems have already been installed year-to-date across 150 stores. The project continues to expand, with an additional 51 stores planned in 2026 and further rollout in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007465701/en/ Toshiba’s ELERA® Self Service successfully deployed across Okay, Okay City, Spar Colruyt Group and Bio-Planet stores in Belgium. The deployment was designed to support a fast, intuitive, and customer-friendly checkout experience, while maintaining the personal interaction that remains important within the convenience retail environment. Across the stores, employees remain present near the self-checkout area to assist customers whenever needed, helping ensure accessibility
Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio ® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older8.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new data regarding the use of Nemluvio for atopic dermatitis and prurigo nodularis to be presented at the 2026 Fall Clinical Dermatology Conference, taking place from October 08-11 in Las Vegas, United States. This includes a new post-hoc analysis from the ARCADIA LTE study showing that in adults and adolescents aged 12 and older who achieved an early response at Week 16 in the ARCADIA trial, Nemluvio achieved deep and lasting skin lesion and itch responses for up to three years.1 The data add to the growing evidence supporting the long-term efficacy of Nemluvio, underscoring Galderma's commitment to advancing the science for people living with moderate-to-severe atopic dermatitis and prurigo nodularis. “Patients and physicians increasingly expect more from treatment than temporary symptom relief. The data presented at Fall Clinical reinforce our confidence in Nemluvio's potential to deliver durable diseas
Fuji Electric Joins Helical Fusion as Strategic Investor and Official Partner as Series B Second Close Raises JPY 3.23 Billion8.10.2026 02:00:00 CEST | Press Release
Helical Fusion Co., Ltd., a fusion energy company developing a Helical Stellarator with the goal of achieving commercially viable fusion power in the 2030s, today announced the completion of a JPY 3.23 billion (approximately USD 20.6 million) Series B second close. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007813917/en/ Helical Fusion and new investors for the Series B 2nd close The round marks another expansion of the industrial coalition forming around Helical Fusion’s Helix Program. Fuji Electric Co., Ltd., one of Japan’s major electrical and industrial equipment manufacturers, has joined Helical Fusion as both an investor and an Official Partner of the Helix Program. Other new investors in the second close include HAZAMA ANDO CORPORATION(https://www.ad-hzm.co.jp/english/), Fujikura Ltd.(https://www.fujikura.co.jp/en/), TOKYO GAS CO., LTD.(https://www.tokyo-gas.co.jp/about/profile/index.html?wovn=en#), KKT LLC(htt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom